SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $345,000 | – | 32,784 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newtyn Management, LLC | 1,540,920 | $2,311,380 | 0.45% |
Deuterium Capital Management, LLC | 11,000 | $16,500 | 0.03% |
Duquesne Family Office | 100,000 | $150 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $169,350 | 0.00% |
LEO BROKERAGE, LLC | 14,845 | $22,268 | 0.00% |
Ergoteles LLC | 15,521 | $23,282 | 0.00% |
UBS Group AG | 3,440 | $5,160 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 15,276 | $22,914 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 11,570 | $17,355 | 0.00% |
BANK OF AMERICA CORP /DE/ | 89,986 | $134,979 | 0.00% |